The Cellometer™ Ascend™ automated cell counter is a benchtop instrument offering fast analysis and reliable cell counts with small sample volumes. Equipped with Matrix™ software, the Cellometer Ascend has multiple pre-defined assays, can analyze numerous cell types, and is 21 CFR Part 11 ready.
For research use only. Not for use in diagnostic procedures.
Accelerate your research workflow with the Cellometer Ascend automated cell counter. Our next generation cell counter is packed with advanced functionalities including autofocus, sample slide detection, and automatic result analysis. The Cellometer Ascend accelerates your lab workflow helping to mitigate human error, all while providing a consistent, standardized cell count.
With its revolutionary design, the Cellometer Ascend has elevated accuracy and reliability in cell counting. Plus, its user-friendly Matrix software incorporates an automated and sophisticated image analysis workflow that delivers reliable results in seconds.
Depth |
13.0 in
|
---|---|
Height |
18.7 in
|
Weight |
10.88 kg
|
Width |
9.9 in
|
21CFR Compatible |
Yes
|
---|---|
Brand |
Revvity
|
Model |
Cellometer Ascend automated cell counter
|
Technology |
Matrix Software
|
Unit Size |
1 Each
|
Are you looking for resources, click on the resource type to explore further.
The need for better profiling is clear, and technological advances are making it possible to optimize clinical trials and...
Streamlining single-cell sequencing workflows using Cellometer and Cellaca high-throughput cell counters
Single-cell sequencing...
The hemacytometer has been an essential tool for hematologists, medical practitioners, and biologists for over a century. In this...
Single-cell sequencing is a rapidly evolving approach to delve into the genomic, transcriptomic, epigenomic, and proteomic...
Technological advancements have rapidly boosted the adoption of single-cell sequencing experiments – by increasing the number of...
Flyer describing the Cellometer Ascend automated cell counter.
We are here to answer your questions.